Searched for
VIVEK PARTHEEBAN
Caplin Point bets big on US, complex injectables to drive next growth phase: COOCaplin Point is building a strong growth runway with over 40 US approvals, a 60-plus product pipeline and aggressive capacity expansion, sa...- The week in 10 stocks: Hudco, Wipro, BEL, Caplin Point, Sun Pharma, HikalFor the week, Sensex lost 255.25 points, or 0.66 per cent, to end at 38,389.
- Lanco Infratech, Hindustan Unilever and USL among stocks in the newsHere's a look at the top stocks that may hog the limelight in today's session.
- USFDA observations minor in nature: Vivek Partheeban, CEO, Caplin PointIn an interview with ET Now, Vivek Partheeban, CEO, Caplin Point, speaks about resumption of supplies from a plant.
- We will continue to grow at 20-25%: Vivek Partheeban, Caplin Point Labs"Over 90 per cent of our revenues are still coming from Latin America and in the next couple of years we see the same trend continuing."
Load More- USFDA observations minor in nature: Vivek Partheeban, CEO, Caplin Point